420 related articles for article (PubMed ID: 34943909)
1. Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Cells; 2021 Dec; 10(12):. PubMed ID: 34943909
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear Antibodies in Systemic Sclerosis: an Update.
Stochmal A; Czuwara J; Trojanowska M; Rudnicka L
Clin Rev Allergy Immunol; 2020 Feb; 58(1):40-51. PubMed ID: 30607749
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
5. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies in systemic sclerosis].
Żebryk P; Puszczewicz M
Postepy Hig Med Dosw (Online); 2015 May; 69():654-60. PubMed ID: 26035026
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
8. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
9. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
11. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
[TBL] [Abstract][Full Text] [Related]
12. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
14. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
[TBL] [Abstract][Full Text] [Related]
15. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies and their clinical characteristics in systemic sclerosis].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.
Poormoghim H; Moghadam AS; Moradi-Lakeh M; Jafarzadeh M; Asadifar B; Ghelman M; Andalib E
Rheumatol Int; 2013 Aug; 33(8):1943-50. PubMed ID: 23344826
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
20. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
